BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 27924364)

  • 1. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
    Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
    Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.
    Kim JH; Kim HS; Kong TY; Lee JY; Kim JY; In MK; Lee HS
    J Pharm Biomed Anal; 2016 Feb; 119():50-8. PubMed ID: 26641707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
    Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
    Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes.
    Kim DK; Liu KH; Jeong JH; Ji HY; Oh SR; Lee HK; Lee HS
    Xenobiotica; 2011 May; 41(5):358-71. PubMed ID: 21294626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
    Chimalakonda KC; Seely KA; Bratton SM; Brents LK; Moran CL; Endres GW; James LP; Hollenberg PF; Prather PL; Radominska-Pandya A; Moran JH
    Drug Metab Dispos; 2012 Nov; 40(11):2174-84. PubMed ID: 22904561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone.
    Yan Z; Caldwell GW; Wu WN; McKown LA; Rafferty B; Jones W; Masucci JA
    Xenobiotica; 2002 Nov; 32(11):949-62. PubMed ID: 12487725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
    Nielsen LM; Holm NB; Olsen L; Linnet K
    Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms.
    Renwick AB; Mistry H; Ball SE; Walters DG; Kao J; Lake BG
    Xenobiotica; 1998 Apr; 28(4):337-48. PubMed ID: 9604298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved.
    Baek MS; Kim JY; Myung SW; Yim YH; Jeong JH; Kim DH
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):381-8. PubMed ID: 11259320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of metabolites and human P450 isoforms involved in the microsomal metabolism of mesaconitine.
    Ye L; Tang L; Gong Y; Lv C; Zheng Z; Jiang Z; Liu Z
    Xenobiotica; 2011 Jan; 41(1):46-58. PubMed ID: 21105783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
    Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N
    Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of BIIB021, an inhibitor of heat shock protein 90, in liver microsomes and hepatocytes of rats, dogs, and humans and recombinant human cytochrome P450 isoforms.
    Xu L; Woodward C; Khan S; Prakash C
    Drug Metab Dispos; 2012 Apr; 40(4):680-93. PubMed ID: 22217465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
    Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cytochrome P450s involved in the metabolism of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1) using human recombinant enzymes and rat liver microsomes in vitro.
    Lu YY; Cheng HX; Wang X; Wang XW; Liu JY; Li P; Lou YQ; Li J; Lu C; Zhang GL
    Xenobiotica; 2017 Aug; 47(8):667-672. PubMed ID: 27910729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of in vitro metabolism of m-nisoldipine in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography-mass spectrometry.
    Yuan L; Jia P; Sun Y; Zhao C; Zhi X; Sheng N; Zhang L
    J Pharm Biomed Anal; 2014 Aug; 97():65-71. PubMed ID: 24816159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.
    Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP
    Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profiling of five flavonoids from Dragon's Blood in human liver microsomes using high-performance liquid chromatography coupled with high resolution mass spectrometry.
    Li Y; Zhang Y; Wang R; Wei L; Deng Y; Ren W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1052():91-102. PubMed ID: 28376352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.